Cognitive issues in Parkinson's disease.
Elmer
Lawrence
L
Parkinson's Disease and Movement Disorder Program, Department of Neurology, Medical College of Ohio at Toledo, 3000 Arlington Avenue, Toledo, OH 43601, USA. lelmer@mco.edu
D006801:Humans; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D003704:Dementia / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D020961:Lewy Body Disease / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use; D010300:Parkinson Disease / Q000175:diagnosis / Q000523:psychology
D000978:Antiparkinson Agents; D018696:Neuroprotective Agents; D018697:Nootropic Agents